Position in KOD
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$12,178,700
+$155,653 QoQ
Shares Held
312,595
-0.9% QoQ
Ownership
0.497%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 200 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 71%
Shared 15%
None 14%
Common Shares in KOD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,163,799,259 across 230 Biotechnology names. KOD ranks #77 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in KOD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,178,700 | 312,595 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $12,023,047 | 315,400 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $9,156,395 | 327,482 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $8,479,658 | 518,000 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,728,660 | 731,545 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,920,753 | 683,543 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $5,186,306 | 521,237 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,292,415 | 495,179 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $865,266 | 368,199 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,244,466 | 426,705 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,328,500 | 437,007 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $1,147,416 | 637,454 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $4,981,495 | 721,956 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $3,947,544 | 636,701 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $4,200,138 | 586,612 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $2,560,838 | 330,858 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,316,293 | 172,290 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,674,583 | 216,915 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $14,608,441 | 172,310 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $9,142,958 | 95,259 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,199,607 | 12,899 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $3,800,039 | 33,513 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,876,628 | 12,774 | Shares | Defined | 2021-03-08 | |
| 2020-03-31 | $676,338 | 14,179 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||